IMMvention Therapeutix is a biotech firm that is currently developing innovative small molecule pan-inflammasome inhibitors for the treatment of various inflammatory diseases. Their unique platform technology utilizes biodegradable biopolymeric nano/micro-particles to harness the immune system. The company's focus is on addressing auto-inflammatory conditions with significant unmet needs, including rheumatoid arthritis, osteoarthritis, gout, and Alzheimer’s disease.

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Chemical drugs	2
Gene therapy	1

Top 5 Target	Count

BACH1(BTB domain and CNC homolog 1)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

IMM-002(IMMvention Therapeutix)	Metabolic Diseases More	Preclinical
IMM-005(IMMvention Therapeutix)	Neurodegenerative Diseases More	Preclinical
IMM-004 ( BACH1 )	Anemia, Sickle Cell More	Preclinical
IMM-11	-	Pending
IMM-09	Inflammation More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis